Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Metastatic Prostate Cancer
Related studies linked through entity extraction aliases.
PRostate Cancer Plasma Integrative Multi-modal Evaluation
- Status
- RECRUITING
- Phase
- N/A
Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate Cancer
- Status
- RECRUITING
- Phase
- NA
Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
7-Days Water-Only Fasting Trial in Prostate Cancer
- Status
- RECRUITING
- Phase
- NA
A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE4
Combination of TURP and Standard Systemic Therapy for MPCa
- Status
- RECRUITING
- Phase
- PHASE2
Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of the Absorption, Distribution, Metabolism, and Elimination of Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-008)
- Status
- COMPLETED
- Phase
- PHASE1
A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes
- Status
- RECRUITING
- Phase
- PHASE3
Remotely Monitored Exercise Interventions in Patients With mCSPC Undergoing ADT (Prostate 006)
- Status
- RECRUITING
- Phase
- NA
Evaluate Safety, Whole-Body Distribution and Radiation Dosimetry in Metastatic Castration Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients
- Status
- RECRUITING
- Phase
- PHASE3
177Lu-PSMA, Niraparib/AA Plus Prednisone for Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2